{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:17:30Z","timestamp":1787314650839,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The 2025 EuDial Consensus systematically compared hemodiafiltration (HDF) to high-flux hemodialysis (HD), highlighting HDF\u2019s superior removal of middle-molecular-weight uremic toxins, potential survival advantages, and immunomodulatory properties. High-Volume HDF (HVHDF), defined by a substitution volume exceeding 23 L per session, was associated with improved cardiovascular outcomes, reduced infection-related mortality, and decreased systemic inflammation. Background\/Objectives: Nevertheless, the consensus refrains from endorsing HDF as the standard of care, citing insufficient evidence to prevent sudden cardiac death, reduce intradialytic hypotension, or significantly lower hospitalization rates compared to HD. Methods: This review critically evaluates the EuDial Consensus, highlighting its methodological strengths while noting potential limitations stemming from an exclusive reliance on randomized controlled trials (RCTs). The exclusion of real-world evidence (RWE) and mechanistic studies may have led to an underestimation of HDF\u2019s broader clinical benefits, particularly in cardiovascular stability, inflammation control, and anemia management. Results: Multiple studies have demonstrated HDF\u2019s capacity to enhance immune function, improve erythropoiesis, and increase the clearance of beta-2 microglobulin (\u03b22M) and other pro-inflammatory toxins. Furthermore, the CONVINCE trial\u2019s economic analysis supports HDF\u2019s cost-effectiveness, especially when considering improved survival and reduced dependency on erythropoiesis-stimulating agents. Conclusions: Future research should integrate RWE and mechanistic insights to better define HDF\u2019s therapeutic potential, particularly concerning anemia control, infection mitigation, and hemodynamic stability. While the EuDial Consensus provides valuable clinical guidance, its conclusions should be contextualized within a broader and evolving evidence base. Given its multidimensional benefits, post-dilution HVHDF is increasingly viewed as a preferred renal replacement therapy modality, warranting wider adoption in clinical practice.<\/jats:p>","DOI":"10.3390\/jcm14093174","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:10:27Z","timestamp":1746389427000},"page":"3174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["High-Volume Hemodiafiltration: Expanding the Evidence Beyond Randomized Trials\u2014A Critical Perspective on the 2025 EuDial Consensus"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-4507","authenticated-orcid":false,"given":"Stefano","family":"Stuard","sequence":"first","affiliation":[{"name":"Global Medical Office, Fresenius Medical Care, 26020 Palazzo Pignano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin W.","family":"Maddux","sequence":"additional","affiliation":[{"name":"Global Medical Office, Fresenius Medical Care, Waltham, MA 02451, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Battaglia, Y., Shroff, R., Meijers, B., Nistor, I., Alfano, G., Franssen, C., Luyckx, V., Liakopoulos, V., Mantovani, A., and Baciga, F. (2025). Haemodiafiltration versus high-flux haemodialysis\u2014A Consensus Statement from the EuDial Working Group of the ERA. Nephrol. Dial. Transpl., gfaf024.","DOI":"10.1093\/ndt\/gfaf024"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJMoa2304820","article-title":"Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure","volume":"389","author":"Blankestijn","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Winter, A., Ferreras, B.A., Carioni, P., Arkossy, O., Anger, M., Kossmann, R., Usvyat, L.A., Stuard, S., and Maddux, F.W. (2025). Real-world effectiveness of hemodialysis modalities: A retrospective cohort study. BMC Nephrol., 26.","DOI":"10.1186\/s12882-024-03934-y"},{"key":"ref_4","unstructured":"(2025, April 24). Dialysis Outcomes Practice Patterns Study (DOPPS) Practice Monitor, Hemodialysis, 2021. Available online: https:\/\/www.dopps.org\/DPM-HD\/."},{"key":"ref_5","first-page":"S94","article-title":"EuCliD (European Clinical Database): A database comparing different realities","volume":"14","author":"Marcelli","year":"2001","journal-title":"J. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/ckj\/sfad168","article-title":"From electronic health records to clinical management systems: How the digital transformation can support healthcare services","volume":"16","author":"Barbieri","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Canaud, B., Strippoli, G., and Davenport, A. (2025). High-Volume Hemodiafiltration Versus High-Flux Hemodialysis: A Narrative Review for the Clinician. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082614"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/sdi.13085","article-title":"Global real-world data on hemodiafiltration: An opportunity to complement clinical trial evidence","volume":"35","author":"Ficociello","year":"2022","journal-title":"Semin. Dial."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000510551","article-title":"Practice Patterns and Outcomes of Online Hemodiafiltration: A Real-World Evidence Study in a Russian Dialysis Network","volume":"50","author":"Neri","year":"2021","journal-title":"Blood Purif."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records","volume":"33","author":"Kim","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cpt.3020","article-title":"Real-World Evidence to Supplement Randomized Clinical Trials: Tocilizumab for Severe COVID-19 Pneumonia vs. a Cohort Receiving Standard of Care","volume":"114","author":"Skarbinski","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jama.2023.4855","article-title":"Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making?","volume":"329","author":"Sheldrick","year":"2023","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cpt.1793","article-title":"Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials","volume":"107","author":"Franklin","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjd.18791","article-title":"Real-world evidence vs. randomized control trials","volume":"182","author":"Deleuran","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5694\/j.1326-5377.2001.tb143250.x","article-title":"Evidence-based medicine: Useful tools for decision making","volume":"174","author":"Craig","year":"2001","journal-title":"Med. J. Aust."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","article-title":"The number, quality, and coverage of randomized controlled trials in nephrology","volume":"15","author":"Strippoli","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1681\/ASN.2012080875","article-title":"High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients","volume":"24","author":"Maduell","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.kint.2017.01.013","article-title":"Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly","volume":"91","author":"Morena","year":"2017","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ndt\/gfs407","article-title":"Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: Results from the Turkish OL-HDF Study","volume":"28","author":"Ok","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1681\/ASN.2010030280","article-title":"Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD","volume":"21","author":"Locatelli","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","first-page":"165","article-title":"Performance of hemodialysis with novel medium cut-off dialyzers","volume":"32","author":"Kirsch","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Barratt, J., and Weitz, I. (2021). Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.712572"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Nongnuch, A., Ngampongpan, W., Srichatrapimuk, S., Wongsa, A., Thongpraphai, S., Boonarkart, C., Sanmeema, N., Chittaganpitch, M., Auewarakul, P., and Tassaneetrithep, B. (2020). Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227719"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40620-022-01350-9","article-title":"Humoral immunity against Covid-19 six months after the Pfizer BNT162b2 vaccine in hemodialysis patients: Data from five dialysis units. Is there a protective role for hemodiafiltration in the COVID-19 pandemic?","volume":"35","author":"Chuva","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3343\/alm.2023.43.5.451","article-title":"Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-CoV-2 in Dialysis Patients","volume":"43","author":"Lioulios","year":"2023","journal-title":"Ann. Lab. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(24)01859-2","article-title":"Haemodiafiltration versus haemodialysis for kidney failure: An individual patient data meta-analysis of randomised controlled trials","volume":"404","author":"Vernooij","year":"2024","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CLEP.S464310","article-title":"Hospitalization Endpoint in Clinical Trials of Outpatient Settings: Using Anti-SARS-CoV-2 Therapy as an Example","volume":"16","author":"Alnafisah","year":"2024","journal-title":"Clin. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.kint.2024.12.018","article-title":"A health economic evaluation of the multinational, randomized controlled CONVINCE trial\u2014Cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis","volume":"107","author":"Schouten","year":"2025","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ndt\/gfx373","article-title":"Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: A meta-analysis of published studies","volume":"33","author":"Roumelioti","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ki.2014.9","article-title":"Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis","volume":"86","author":"Bots","year":"2014","journal-title":"Kidney Int."},{"key":"ref_31","first-page":"S128","article-title":"[The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum]","volume":"21","author":"Aucella","year":"2004","journal-title":"Giomale Ital. Nefrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000322400","article-title":"Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: Effect on ESA requirement","volume":"31","author":"Bolasco","year":"2011","journal-title":"Blood Purif."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/sdi.13037","article-title":"Hemodiafiltration improves red blood cell lifespan in patients with end-stage renal disease","volume":"35","author":"Jiang","year":"2022","journal-title":"Semin. Dial."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000063103","article-title":"Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration","volume":"20","author":"Lin","year":"2002","journal-title":"Blood Purif."},{"key":"ref_35","unstructured":"Stuard, S. (2025, April 24). Redefining the Value of Hemodiafiltration: A Commentary on the 2025 EuDial Consensus and the CONVINCE Cost-Utility Analysis. Nephrol. Dial. Transpl. 2025, gfaf024. Available online: https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfaf024\/8003757?login=false."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.kint.2018.10.036","article-title":"Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis","volume":"95","author":"Kikuchi","year":"2019","journal-title":"Kidney Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:26:49Z","timestamp":1760030809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14093174"],"URL":"https:\/\/doi.org\/10.3390\/jcm14093174","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]}}}